Clinical Internal Dosimetry and Biodistribution of 177Lu-DOTA-Trastuzumab in HER2-Positive Metastatic and Locally Advanced Breast Carcinoma

Yoga S. Narwadkar, Rahul V. Parghane, Sudeep Sahu, Sangita Lad, Kamal Deep, Gaurav Wanage, Tejal Suralkar, Sharmila Banerjee, Sudeep Gupta, Sandip Basu, Rajendra A. Badwe

Open source

DOI: 10.1097/rlu.0000000000005067
Published: 2024-02-01
Container: Clinical Nuclear Medicine
Publisher: Ovid Technologies (Wolters Kluwer Health)
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1097/rlu.0000000000005067,
  title = {Clinical Internal Dosimetry and Biodistribution of 177Lu-DOTA-Trastuzumab in HER2-Positive Metastatic and Locally Advanced Breast Carcinoma},
  author = {Yoga S. Narwadkar and Rahul V. Parghane and Sudeep Sahu and Sangita Lad and Kamal Deep and Gaurav Wanage and Tejal Suralkar and Sharmila Banerjee and Sudeep Gupta and Sandip Basu and Rajendra A. Badwe},
  year = {2024},
  journal = {Clinical Nuclear Medicine},
  doi = {10.1097/rlu.0000000000005067},
  url = {https://doi.org/10.1097/rlu.0000000000005067}
}

RIS

TY  - JOUR
TI  - Clinical Internal Dosimetry and Biodistribution of 177Lu-DOTA-Trastuzumab in HER2-Positive Metastatic and Locally Advanced Breast Carcinoma
AU  - Yoga S. Narwadkar
AU  - Rahul V. Parghane
AU  - Sudeep Sahu
AU  - Sangita Lad
AU  - Kamal Deep
AU  - Gaurav Wanage
AU  - Tejal Suralkar
AU  - Sharmila Banerjee
AU  - Sudeep Gupta
AU  - Sandip Basu
AU  - Rajendra A. Badwe
PY  - 2024
JO  - Clinical Nuclear Medicine
DO  - 10.1097/rlu.0000000000005067
UR  - https://doi.org/10.1097/rlu.0000000000005067
ER  -

APA

Narwadkar, Y. S., Parghane, R. V., Sahu, S., Lad, S., Deep, K., Wanage, G., Suralkar, T., Banerjee, S., Gupta, S., Basu, S., & Badwe, R. A. (2024). Clinical Internal Dosimetry and Biodistribution of 177Lu-DOTA-Trastuzumab in HER2-Positive Metastatic and Locally Advanced Breast Carcinoma. Clinical Nuclear Medicine. https://doi.org/10.1097/rlu.0000000000005067

Source records

crossref · retrieved 2026-09-26T04:03:30.509Z